Skip to main content

Table 2 Lipid alterations in all patients

From: Predictive value of a reduction in the level of high-density lipoprotein-cholesterol in patients with non-small-cell lung cancer undergoing radical resection and adjuvant chemotherapy: a retrospective observational study

Lipids

Mean ± SD

P valueф

Cholesterol (mmol/L)

 

< 0.001

 Pre-chemotherapy level

4.73 ± 1.02

 Post-chemotherapy level

5.51 ± 1.00

 

 Differencea

0.78 ± 0.96

 

Triglyceride (mmol/L)

 

< 0.001

 Pre-chemotherapy level

1.22 ± 0.57

 

 Post-chemotherapy level

1.51 ± 0.81

 

 Differencea

0.29 ± 0.069

 

HDL-C (mmol/L)

 

< 0.001

 Pre-chemotherapy level

1.20 ± 0.32

 

 Post-chemotherapy level

1.44 ± 0.35

 

 Differencea

0.24 ± 0.36

 

LDL-C (mmol/L)

 

< 0.001

 Pre-chemotherapy level

2.98 ± 0.91

 

 Post-chemotherapy level

3.50 ± 0.88

 

 Differencea

0.52 ± 0.76

 

ApoA-I (g/L)

 

< 0.001

 Pre-chemotherapy level

1.17 ± 0.28

 

 Post-chemotherapy level

1.47 ± 0.27

 

 Differencea

0.30 ± 0.30

 

ApoB (g/L)

 

< 0.001

 Pre-chemotherapy level

0.98 ± 0.24

 

 Post-chemotherapy level

1.08 ± 0.24

 

 Differencea

0.10 ± 0.21

 
  1. Data are mean ± standard deviations
  2. Abbreviations: SD standard deviations, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, ApoA-I apolipoprotein A-I, ApoB apolipoprotein B
  3. aDifference = lipids post-chemotherapy –lipids pre-chemotherapy
  4. Ñ„Compared with paired t-test